Medicare Enrolled
Dr. Fadi El Atat, MD
Cardiovascular Disease · Montclair, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. El Atat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El Atat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El Atat
Dr. Fadi El Atat is a cardiovascular disease specialist in Montclair, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. El Atat performed 2,701 Medicare services across 1,898 unique beneficiaries.
Between the years covered by Open Payments, Dr. El Atat received a total of $8,691 from 52 pharmaceutical and/or device companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El Atat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 49% volume in NJ
$8,691 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,701
Medicare services
Top 49% in NJ for cardiovascular disease
1,898
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~142 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
900 | $74 | $200 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
219 | $163 | $775 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
203 | $155 | $675 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
196 | $149 | $542 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
170 | $147 | $460 |
| Ultrasound of arm arteries or grafts An ultrasound exam of the arteries in one arm or any arterial grafts present. This imaging test uses sound waves to visualize blood flow and vessel structure. |
165 | $90 | $471 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
137 | $216 | $595 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
135 | $59 | $650 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
110 | $68 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
93 | $102 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
46 | $12 | $55 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
45 | $32 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $34 | $100 |
| ECG, 1-3 leads with physician review A simple electrocardiogram recording using one to three leads. A physician reviews the results. |
39 | $6 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
39 | $97 | $250 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
37 | $244 | $837 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $146 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $141 | $400 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
24 | $70 | $350 |
| Cardiac catheterization | 20 | $193 | $2,315 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
20 | $12 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
40.2% medium
51.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,691
Total received (2018-2024)
Avg $1,242/year across 7 years
Top 23% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
580
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,691 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$873
2023
$1,312
2022
$1,234
2021
$1,207
2020
$971
2019
$1,447
2018
$1,647
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$451
Novartis Pharmaceuticals Corporation
$162
Xeris Pharmaceuticals, Inc.
$60
Novo Nordisk Inc
$49
Kiniksa Pharmaceuticals International, plc
$27
ShockWave Medical, Inc
$23
Merck Sharp & Dohme LLC
$17
ACADIA Pharmaceuticals Inc
$15
Intra-Sana Laboratories
$14
Amgen Inc.
$14
Esperion Therapeutics, Inc.
$14
Tactile Systems Technology Inc
$14
CashFlow Solutions, LLC
$13
Top 3 companies account for 77.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,187
GlaxoSmithKline, LLC.
$975
Novo Nordisk Inc
$879
Lilly USA, LLC
$614
Novartis Pharmaceuticals Corporation
$452
Amgen Inc.
$446
Boehringer Ingelheim Pharmaceuticals, Inc.
$428
Merck Sharp & Dohme Corporation
$400
Merck Sharp & Dohme LLC
$275
Bayer HealthCare Pharmaceuticals Inc.
$268
Janssen Pharmaceuticals, Inc
$266
PFIZER INC.
$205
Amarin Pharma Inc.
$182
Gilead Sciences, Inc.
$94
Supernus Pharmaceuticals, Inc.
$87
Horizon Therapeutics plc
$82
Xeris Pharmaceuticals, Inc.
$60
ARBOR PHARMACEUTICALS, INC.
$60
SANOFI-AVENTIS U.S. LLC
$51
Mannkind Corporation
$42
Ironwood Pharmaceuticals, Inc
$41
Esperion Therapeutics, Inc.
$41
Endo Pharmaceuticals Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$31
Abbott Laboratories
$30
Kowa Pharmaceuticals America, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
Kiniksa Pharmaceuticals International, plc
$27
E.R. Squibb & Sons, L.L.C.
$26
BOSTON SCIENTIFIC CORPORATION
$25
G Medical Diagnostic Services, Inc.
$25
ShockWave Medical, Inc
$23
Philips Electronics North America Corporation
$18
Lexicon Pharmaceuticals, Inc.
$17
Boston Scientific Corporation
$17
IRONWOOD PHARMACEUTICALS, INC
$16
United Therapeutics Corporation
$16
ACADIA Pharmaceuticals Inc
$15
DEXCOM, INC.
$15
Intra-Sana Laboratories
$14
ABIOMED
$14
Adhera Therapeutics, Inc.
$14
Kiniksa Pharmaceuticals, Ltd.
$14
Tactile Systems Technology Inc
$14
West-Ward Pharmaceuticals
$13
CashFlow Solutions, LLC
$13
Mylan Specialty L.P.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Hikma Pharmaceuticals USA
$12
RedHill Biopharma Inc.
$11
Horizon Pharma plc
$11
ZOLL Circulation Inc
$8
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANORO · ANORO ELLIPTA · Adempas · Aimovig · Amitiza · Arcalyst · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · CHANTIX · Cardiac Monitoring Suite · Corlanor · DEXCOM G6 TRANSMITTER · DUEXIS · DUZALLO · ELIQUIS · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FASENRA · Flexitouch Plus · FreeStyle Libre · GVOKE HYPOPEN · General - Therapies · HeartMate · Horizant · INVOKANA · Impella · Inpefa · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LYMPHA PRESS OPTIMAL PLUS(US) BT · LYRICA · Linzess · Livalo · MOUNJARO · MULTAQ · Mitigare · NASCOBAL · NEXLETOL · NUPLAZID · ONPATTRO · OXTELLAR XR · Ozempic · PENNSAID · PRALUENT · PRESTALIA · RELTONE 200 MG · Repatha · Rybelsus · SEGLENTIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TYVASO · Talicia · TherOx DS2 Console · Tresiba · Trintellix · VERQUVO · Vascepa · Victoza · WATCHMAN · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,628
Per 100K population
190.6
County median income
$76,712
Nearest hospital
HACKENSACK MERIDIAN MOUNTAINSIDE MEDICAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. El Atat is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. El Atat experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. El Atat performed 900 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El Atat receive payments from pharmaceutical companies?
Yes. Dr. El Atat received a total of $8,691 from 52 companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El Atat's costs compare to other cardiologists in Montclair?
Dr. El Atat's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El Atat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Montclair
Browse cardiologists in Montclair ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology